2003年～2005年我院门急诊麻醉药品应用分析  

Analysis on Narcotics used in out-patient and emergency department of our hospital during 2003～2005

作　　者：郑晓林[1] 

机构地区：[1]广西医科大学第五附属医院药剂科,柳州545001

出　　处：《中国药物应用与监测》2007年第2期28-30,共3页Chinese Journal of Drug Application and Monitoring

摘　　要：目的:调查我院3年来门急诊麻醉药品的应用情况,为临床合理使用麻醉药品提供参考。方法:统计2003年～2005年我院门急诊麻醉药品处方,对麻醉药品处方数量、用量、用药频度以及癌症患者用药情况进行分析。结果:3年来我院麻醉药品DDDs缓慢增长;盐酸哌替啶2004年DDDs增长明显,3年中每年用于癌症患者百分比依次为23.97%、27.55%、25.14%;美菲康用于癌症患者的百分比为100%。结论:我院门急诊麻醉药品应用欠合理,应减少癌症患者盐酸哌替啶用量。Objective：To examine the situation of narcotics used in out-patient and emergency department of our hospital in the last 3 years in order to provide preferences for rational use of narcotics in clinic.Methods：The narcotics prescription during 2003~2005 were collected and the dosage, DDDs and narcotics＇ usage of cancer patient were analyzed.Results：DDDs of narcotics in our hospital was increased slowly in the last 3 years. DDDs of Pethidine hydrochloride increased evidently in 2004, and the ratios of administration to cancer patient in turn each year was 23.97%, 27.55% and 25.14% respectively, ratio of Morphine Hydrochloride sustained-release tablets was 100%.Conclusion：The administration of narcotics in our hospital was not rational, and the usage of Pethidine Hydrochloride to cancer patient should be reduced.

关 键 词：麻醉药品 用药频度 分析 

分 类 号：R96[医药卫生—药理学]